GlassScriptPhysician profile
Blaine P Carmichael
NPI 1386633121
$15,754.48
in general payments reported to CMS, 2019-2025
20 companies · $88.29 in 2025
The $88.29 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,755 · 2022: $3,312 · 2023: $4,205 · 2024: $395 · 2025: $88.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,231 · Food and Beverage: $1,407 · Travel and Lodging: $49.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,231.25 |
| Food and Beverage | $1,407.01 |
| Travel and Lodging | $49.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13,472.64 | 2021-2024 | |
| Allergan, INC. | $750.00 | 2021 | |
| Novo Nordisk INC | $276.37 | 2021-2024 | Rybelsus, Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $215.35 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $137.62 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $135.98 | 2022-2025 | Airsupra |
| Lilly USA, LLC | $109.88 | 2022-2024 | Jardiance, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $105.85 | 2022-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Avanir Pharmaceuticals, INC. | $97.93 | 2021-2022 | |
| Medtronic, INC. | $83.65 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $58.55 | 2022-2023 | Seglentis, Livalo |
| Amgen INC. | $48.35 | 2023-2024 | Repatha, Otezla |
| Exact Sciences Corporation | $48.27 | 2023 | Cologuard Collection Kit |
| Abbott Laboratories | $46.68 | 2022 | |
| Pfizer INC. | $44.46 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $33.90 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $26.09 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $25.78 | 2022 | |
| Sanofi Pasteur INC. | $19.04 | 2021 | |
| Horizon Therapeutics Plc | $18.09 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blaine Carmichael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.